Published: Sep-2022|  Format: PDF | MBI Research |  Number of pages: 138 | Code: MBI-171436

Next Generation Sequencing Market Size, Share, Growth & Demand Analysis Report by Technology (Sequencing by Synthesis, Sequencing by Ligation, Ion Semiconductor Sequencing, Pyrosequencing and Other Technologies) by Application (Diagnostics, Reproductive Health, Agriculture and Animal Research, Biomarkers and Cancer, and Other Applications) Forecast Report 2022-2030

Select a Format




 Buy Now

Market Overview:

The Global Next Generation Sequencing Market size was valued at USD 6.23 billion in 2021 and is projected to register a valuation of USD 23.18 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 15.2% over the forecast period 2022-2030.

Market Introduction:

The increasing use of NGS technology in clinical diagnosis, cost, speed, and accuracy of this sequencing method are a major factors driving the growth of the market. NGS diagnostic technology has the potential benefit of determining the genetic sequence of the virus and helping scientists understand the mutation.

Next Generation Sequencing (NGS) is a powerful platform that has enabled the sequencing of thousands to millions of DNA molecules at the same time. This powerful tool is revolutionizing fields such as personalized medicine, clinical diagnostics, and genetic diseases by offering a high throughput option with the capability to sequence multiple individuals at the same time. Sanger Sequencing, first developed in the 1900s, is the gold standard for DNA sequencing and it is still used today widely for routine sequencing applications and to validate.
It takes advantage of a high-fidelity DNA-dependent polymerase to generate a complimentary copy to a single-stranded DNA template.

Covid-19 Impact Analysis by Market Business Insights:

The outbreak of COVID-19 and the subsequent extent of lockdown have impacted the next-generation sequencing market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times including production shutdowns, transportation, healthcare, supply chain disruptions, cost increases, and workforce disruptions, which negatively affect the next-generation sequencing industry in terms of revenue.

During the COVID-19 pandemic, government officials around the world are working relentlessly with the private sector to market NGS technology as a potential diagnostic tool. As next generation sequencing plays an essential role in clinical laboratories to fight against the COVID-19 pandemic. Researchers and scientists fought against the COVID-19 pandemic together to identify a new strain of coronavirus from organisms with no prior knowledge.

However, the COVID-19 pandemic had a positive impact on the global market, due to increased research and development activities by the major players to use next-generation sequencing technologies for the diagnosis of COVID-19 infections.

What are the Global Next Generation Sequencing Market Drivers?

The growing demand for NGS technology by pharmaceutical and biopharmaceutical companies and rising technological advancements in next-generation sequencing in developed countries are the factors propelling the market.

The rising population, and rising incidence of cancer and infectious diseases are expected to boost the next-generation sequencing market owing to the increasing applications of next-generation sequencing in the fields of transmissible diseases and oncology.

The rise in the development of personalized drugs, NGS bioinformatics solutions, growth in pre-sequencing, and cloud computing are some of the opportunities for the global next-generation sequencing market. However, the management and storage of the huge data generated by sequencing and its interpretation pose some challenges to the industry.

Who are the Major Companies in the Global Next Generation Sequencing Market?

  • Illumina
  • F. Hoffman-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies
  • PierianDx
  • Genomatix GmbH
  • DNASTAR, Inc.
  • Perkin Elmer, Inc.
  • Eurofins GATC Biotech GmbH
  • BGI

Global Next Generation Sequencing Market Segmentation:

The Global next-generation sequencing market is segmented by orbit type, application, end-user, and region. By technology Sequencing by Synthesis, Sequencing by Ligation, Ion Semiconductor Sequencing, Pyrosequencing, Other Technologies. By application Diagnostics, Reproductive Health, Agriculture and Animal Research, Biomarkers and Cancer, and Other Applications. By region Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.

By Technology:

Sequencing by synthesis segment is leading the overall next-generation sequencing market in 2021 and is expected to grow at the fastest CAGR during the forecast period.

  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Ion Semiconductor Sequencing
  • Pyrosequencing
  • Other Technologies

By Application:

On the basis of application, clinical applications are the largest segment of the market, primarily due to the growing incidence of cancer and the increasing volume of diagnostic procedures and treatment rates for the disease.

  • Diagnostics
  • Reproductive Health
  • Agriculture and Animal Research
  • Biomarkers and Cancer
  • Other Applications

Regional Analysis by Market Business Insights:

The global next-generation sequencing market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.

North America will witness rapid growth in the market.

North America is expected to hold lion's share of the market in the near future. The US region is a major market for the key players. Next-generation sequencing technology is acquiring popularity as a routine clinical diagnostic test, particularly with the COVID-19 pandemic in this region.

The equipment/Instrument segment in the US is expected to rapidly grow in the forecast period from 2022 to 2030 because of a large number of manufacturers who are distributing Instruments to various research laboratories and others.

Report Coverage:

Market Segmentation:

By Technology

  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Ion Semiconductor Sequencing
  • Pyrosequencing
  • Other Technologies

By Application

  • Diagnostics
  • Reproductive Health
  • Agriculture and Animal Research
  • Biomarkers and Cancer
  • Other Applications

By Region

North America

  • The US
  • Canada
  • Mexico

Europe

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Inquiry before buying

Request Sample

Request for Discount

Latest News

Nitric Acid Market Size, Share, Trend Analysis 2022 to 2030

04-Feb-2023 | Chemicals & Materials

Our new latest report titled, Global Nitric Acid Market, comes up with a comprehensive analysis of the industry, including emerging trends and current development of the market. Nitric acid is a colorless liquid that is widely used in a variety ...

Global Robotics Surgical Simulation Systems Market to Grow at a (CAGR) of 16.8% during the Forecast Period 2022-2030

28-Dec-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global Robotics Surgical Simulation Systems Market is projected to reach USD 1.71 billion by 2030. Growth in this market is primarily driven by robotic-assisted surgery, technologi ...

Global CRISPR Technology Market to Grow at a (CAGR) of 19.6% during the Forecast Period 2022-2030

27-Dec-2022 | Biotechnology

As specified in our exclusive report, the global CRISPR Technology Market is projected to reach USD 8.2 billion by 2030. The global CRISPR technology market is driven by the increasing focus of market players in CRISPR-CAS9 technology; availability of g ...

Global Gallium Nitride Semiconductor Devices Market to Grow at a (CAGR) of 4.9% during the Forecast Period 2022-2030

26-Dec-2022 | Semiconductor

As specified in our exclusive report, the Global Gallium Nitride Semiconductor Devices Market is projected to reach USD 26.1 billion by 2030. The advantages, such as faster device speed, higher energy efficiency, and lower cost offer ...

Global Lactose Free Dairy Products Market to Grow at a (CAGR) of 7.6% during the Forecast Period 2022-2030

24-Dec-2022 | Food & Beverage

As specified in our exclusive report, the global Lactose Free Dairy Products Market is projected to reach USD 23.8 billion by 2030. The percentage of people with lactose intolerance varies greatly from country to country and continent to continent, ...

More News...